Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$0.55 - $1.04 $7,155 - $13,530
-13,010 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$1.22 - $1.65 $53,070 - $71,775
-43,500 Reduced 76.98%
13,010 $20,000
Q1 2021

May 14, 2021

BUY
$1.18 - $2.62 $4,720 - $10,480
4,000 Added 7.62%
56,510 $87,000
Q4 2020

Feb 12, 2021

BUY
$1.05 - $2.24 $2,730 - $5,824
2,600 Added 5.21%
52,510 $55,000
Q3 2020

Nov 09, 2020

BUY
$1.7 - $6.41 $84,847 - $319,923
49,910 New
49,910 $101,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.